Executive Committee
Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.
Vasant (Vas) Narasimhan, M.D.

Vasant (Vas) Narasimhan, M.D.
Chief Executive Officer of Novartis
Steven Baert

James (Jay) Bradner, M.D.

James (Jay) Bradner, M.D.
President of Novartis Institutes for BioMedical Research (NIBR)
Thomas N. Kendris

Harry Kirsch

Steffen Lang, Ph.D.

Steffen Lang, Ph.D.
Global Head of Novartis Technical Operations (NTO)
Klaus Moosmayer, Ph.D.

Richard Saynor

Susanne Schaffert, Ph.D.

John Tsai, M.D.

John Tsai, M.D.
Head of Global Drug Development and Chief Medical Officer for Novartis
Marie-France Tschudin

Robert Weltevreden

Other Members of Senior Management
Other Members of Senior Management
Bertrand Bodson

Lutz Hegemann, M.D., Ph.D.

Natacha Theytaz

Natacha Theytaz
Global Head of Novartis Business Assurance & Advisory and Head of Internal Audit
Michael Willi

Michael Willi
Chief Communications Officer, Communications & Engagement, of Novartis
Corporate Governance
Novartis is fully committed to good corporate governance.